In contrast, expression of intrinsic ‘stemness’ genes such as SOX2, OLIG2 and FOXG1 in glioma cells was unaffected by 11b+CM treatment (Figure S5F), giving no reason to suspect that interferon treatment at these levels compromises self-renewal or viability. The gene discussed is FOXG1; the disease is central nervous system cancer.